Engaging with customers in a digital world

As part of our series on customer experience in pharma, in partnership with Indegene, Ipsen’s Paul Murasko explains the many ways digital can enhance the customer journey – so long as t

Ipsen craters as pricey rare disease drug is put on hold aga...

Allergan gets FDA okay for paediatric Botox use

Ipsen adds Blueprint's FOP rare disease drug to pipeline for...

Ipsen has added to its rare diseases pipeline after striking an agreement with US biotech Blueprint for a  licence to develop and market a drug for the rare disease fibrodysplasia ossifican

Ipsen launches new syringe for rare disease blockbuster

Ipsen will be launching a new pre-filled syringe for its blockbuster rare disease drug Somatuline (lanreotide) in the EU.